Showing results (191-200 of 3,276) with videos related to

Sort By:
Pageof 328
Cureus|October 11, 2024
Prolonged Peritoneal Attack: A Rare but Crucial Clinical Presentation of Familial Mediterranean FeverHirohisa Fujikawa, Takayuki Ando, Junichi Hirahashi
The Journal of Physical Chemistry. B|June 30, 2006
Efficient fabrication and enhanced photocatalytic activities of 3D-ordered films of titania hollow spheresYuanzhi Li, Toyoki Kunitake, Shigenori Fujikawa
International Journal of Systematic and Evolutionary Microbiology|July 26, 2021
Pseudomonas lactucae sp. nov., a pathogen causing bacterial rot of lettuce in JapanHiroyuki Sawada, Takashi Fujikawa, Mamoru Satou
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|December 3, 2013
Three-dimensional fast imaging employing steady-state acquisition MRI and its diagnostic value for lumbar foraminal stenosisOsamu Nemoto, Akira Fujikawa, Atsuko Tachibana
Stroke|April 1, 1994
Background factors and clinical symptoms of major depression with silent cerebral infarctionT Fujikawa, S Yamawaki, Y Touhouda
The Journal of Organic Chemistry|July 8, 2017
Laterally π-Extended Dithia[6]helicenes with Heptagons: Saddle-Helix Hybrid MoleculesTakao Fujikawa, Yasutomo Segawa, Kenichiro Itami
Membranes|December 6, 2018
Thickness Effect on CO₂/N₂ Separation in Double Layer Pebax-1657®/PDMS MembranesRoman Selyanchyn, Miho Ariyoshi, Shigenori Fujikawa
European Journal of Histochemistry : EJH|February 13, 2020
Expression, localization and synthesis of small leucine-rich proteoglycans in developing mouse molar tooth germAngammana Randilini, Kaoru Fujikawa, Shunichi Shibata
Avian Pathology : Journal of the W.V.P.A|December 1, 1996
Correlation between neutralizing antibody titre and protection from tenosynovitis in avian reovirus infectionsK Takase, H Fujikawa, S Yamada
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 30, 2008
Cost-effectiveness analysis: controlled-release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-Combi) studyIkuo Saito, Keita Fujikawa, Takao Saruta, et al.
Pageof 328